Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.
Liraglutide in an older adolescents with obesity: a randomised, double-blind, placebo-controlled 5-week trial to assess the safety, tolerability and pharmacokinetics of lithium in adolescents aged 12-17 years.